Clinical Trial Update: Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating perifosine in patients with metastatic or recurrent malignant melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma
• Melanoma

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED